top of page
![](https://static.wixstatic.com/media/949e0e_4b9afcbfd563403da0c9b7462a20f4d6~mv2.jpg/v1/fill/w_1440,h_774,al_c,q_85,enc_avif,quality_auto/949e0e_4b9afcbfd563403da0c9b7462a20f4d6~mv2.jpg)
Evan Atchley
PharmD, BCOP
Rotations
Inpatient Leukemia, Inpatient Cellular Therapy
Education
PharmD: University of Colorado Skaggs School of Pharmacy
Residency Training
PGY1: University of Illinois at Chicago
PGY2: Oncology: Memorial Sloan Kettering Cancer Center
![Evan Atchley](https://static.wixstatic.com/media/8fc367_c2b990d3bfa849028df8b1584c1db975~mv2.png/v1/fill/w_284,h_262,al_c,lg_1,q_85,enc_avif,quality_auto/UCM%20Logol.png)
Practice Interests
Acute Leukemias, Allogeneic Hematopoietic Cell Transplantation, Clinical Research
Professional Affiliation
Recent Publications
Atchley E, Weis TM, Derkach A, et al. Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia. Leuk Res. 2023;130:107311. doi:10.1016/j.leukres.2023.107311
Academic and/or National Presentations
Current Research
bottom of page